Log in to your Inderes Free account to see all free content on this page.
Ziccum
0.467
SEK
+21.93 %
ZICC
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
2 following
+21.93%
-53.21%
-86.14%
-91.33%
-93.2%
-92.45%
-95.33%
-96.1%
-91.18%
Ziccum is a Swedish pharmaceutical company that develops new preparations of biological medicines. With the company's patented LaminarPace technology, dry preparation forms are developed for products that are currently available in liquid form. Most of the business is found around the Nordic region, and in addition to the main business, the company offers various related products. The company's head office is in Lund.
Read moreMarket cap
13.79M SEK
Turnover
36.6K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
29.1.
2025
Annual report '24
ShowingAll content types
Ziccum announces outcome of rights issue
Ziccum announces preliminary outcome in rights issue
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio